A retrospective analysis of 93 patients undergoing 128 re-explorations
for persistent or recurrent hypercalcaemia is presented. Seventy-six
patients (82 per cent) became normocalcaemic after between one and fiv
e reoperations. Nine patients had hypercalcaemia caused by sarcoidosis
, familial hypocalciuric hypercalcaemia or metastatic disease, and two
had parathyroid carcinoma. Fifteen patients (16 per cent) developed p
ermanent hypoparathyroidism requiring vitamin D and/or calcium therapy
and nine had permanent recurrent laryngeal nerve paralysis. Undetecte
d adenomas (41 cases) and inadequate resection in hyperplastic disease
(28) were the predominant causes of initial failure. Reoperation for
persistent or recurrent hyperparathyroidism restored normocalcaemia in
the majority of patients. This 'cure' was achieved at the cost of con
siderable morbidity and a careful risk-benefit analysis of each patien
t is recommended before performing reoperative parathyroid surgery.